Microbial biotransformation of naturally occurring pungent sesquiterpene 1,2-dials, polygodial and cinnamodial, and a diterpene 1,2-dial, sacculatal as well as their tetrahydro derivatives was carried out by using Aspergillus niger. The pungent polygodial and sacculatal are toxic against A. niger not to produce any metabolites while A. niger biotransformed cinnamodial to the lactonized products in small amount. On the other hands, the dihydroxy derivatives of the former two dialdehydes were bioconverted by the same fungus to give hydroxy-, oxo-, carboxylic-and epoxy-products. The stereostructures of each metabolite and their metabolic pathways were described.
Polygodial (1) possessing very strong pungent taste, and piscicidal and antimicrobial activity was isolated from the higher plants, Polygonum hydropiper, P. minus and P. punctatum and the liverwort, Porella vernicosa complex [5] [6] [7] [8] . Sacculatal isolated from the liverwort, Trichocoleopsis sacculata and Pellia endiviifolia also shows very hot taste and antimicrobial and anti-HIV activity [9] [10] [11] .
In order to obtain the substrate, polygodial (1), a high amount of the fresh Polygonum hydropiper collected in Tokushima was extracted with diethyl ether to afford a green pungent extract, followed by chromatography on silica gel to furnish (-)-polygodial (1) . An Erlenmeyer flask containing Czapek-peptone was inoculated with a suspension of A. niger and incubated at 30°C for 3 days in a rotary shaker. A small amount of 1 (20 mg) was cultured by A. niger for 3 days under the same condition as described above, no metabolites were obtained. Therefore, polygodial (1) was reduced to polygodiol (2) by LiAlH 4 , followed by bioconversion by using the same fungus for 2-21 days (Figure 1 ).
When polygodiol (2, 20 mg) was incubated with A. niger for 3 days, a hydroxylated product (7) was obtained in 70.5% yield as colorless needles. The molecular formula, C 15 H 26 O 3, was established by HREIMS spectrum, indicating that compound 7 possessed one more hydroxyl group in the original substrate. This fact was confirmed by the formation of a triacetate (7a) by the acetylation. The position of a newly introduced -hydroxy group at C-3 was confirmed by the coupling patterns of the 1 H NMR spectra of 7 and 7a as well as HMBC and NOESY spectra of 7. In fact, the 1 H and 13 C NMR spectra of 7 were completely identical to those of the natural product, drim-7-ene-3,11,12-triol, isolated from the fungus Marasmius oreades [12] .
Polygodiol (2) (200 mg) was cultured for 4 days as a large scale in the same condition as described above to afford two more metabolites (8, 1.6%) and (9, 3.8%) as small amounts, together with the substrate (2, 8.2%) and the former described metabolite (7, 20.2% ). An amount of the substrate may be important to produce two additional metabolites rather than incubation time.
The HREIMS of 8 showed the same molecular formula as the metabolites 7, and its IR spectrum indicated the absorption at 3353 cm -1 ascribe to hydroxy group. In the 1 H and 13 C-NMR spectra (Table 1) , one methyl group connected to tertiary carbon disappeared and one oxo methylene proton signals ( H 3.01 and 3.31, each doublet;  c 71.8) was newly confirmed, indicating that one of the 1,1-dimethyls at C-4 or methyl group at C-10 was hydroxylated. The position and the stereochemistry at the -hydroxylated methyl group at C-15 was confirmed by the 1 H-1 H COSY, HMQC, HMBC ( Figure 2a ) and NOESY spectra ( Figure  2b ) of 8. In HMBC spectrum, the methylene protons (  , 3.01, 3.31) at C-14 were correlated to C-3, 4, 5 and 13 and NOE was observed between H-14 and H-5, and H-6 by NOESY. Thus the structure of 8 was characterized as drim-7-ene-11,12,14-triol.
Compound 9, had the molecular formula, C 15 H 24 O 3 which was established by HREIMS. The IR spectrum showed the absorption bands at 3389 and 1701 cm -1 assignable to a hydroxy, and a ketone groups which was confirmed by the presence of the signal at  c 218.8 in the 13 C NMR spectrum. The 1 H and 13 C NMR of 9 ( Table  1) indicating that compound 9 was 11,12-dihydroxydrim-7-en-3-one. This assumption was confirmed by the cross peaks of H-1, 2, 5, 13 and 14 to C-3 in HMBC spectrum.
The same bioconverted products (7, 66-70%) and 6-hydroxypolygodiol (7b, 5-10%) were obtained from the metabolites of polygodiol (2) by the fungus, Mucor plumbeus for 2-6 days [13] . The similar drimane sesquiterpene mono-alcohol drimenol (7c) was incubated with M. plumbeus to give 3-hydroxy-(7d) and 6-hydroxydrimenol (7e), along with 3-hydroxy-7,8-epoxydrimenol (7f) [13] . Rhizopus arrhizus and A. niger also bioconverted drimenol (7c) to 3-hydroxydrimenol (7d) [13, 14] as shown in Figure 3 , while the present A. niger converted polygodiol (2) to C-3 oxo-(9) and C-13 hydroxy products (8) , together with C-3-hydroxy product (7, 20-70%) for 3-4 days. From yield of the metabolites from 2 and 7c, the regio-and stereoselective introduction of a hydroxy group at C-3 predominantly occurred in these microorganisms.
Cinnamodial (3) obtained from the Malagasy medicinal plant, Cinnamosma fragrans shows pepper like pungency, antimicrobial and insect antifeedant activity [15, 16] . Compound (3, 200 mg) was incubated with A. niger in the same manner as previously described to yield three metabolites, (10, 2.2%), (11, 0.05%) and (12, 0.2 %), respectively ( Figure 4 ). The two aldehyde protons and carbonyl signals present in the substrate (3) disappeared and a trisubstituted double bond, an acetate and a hydroxy group on quaternary carbon retained from the 1 H and 13 C-NMR spectra (Table 2) , instead an oxygenated On the basis of the molecular formula and the above spectral data, compound 10 was suggested to be a tricyclic structure with a hemiacetal and a tertiary hydroxy group. The conclusive structure of 10 was established by the connectivity of HMBC spectrum in which cross-peaks between H-12 and C-7, 8, 9, 11, and H-11 and C-9 and C-12 were observed, respectively. The stereochemistry of secondary hydroxy group at C-11 was confirmed to be by the NOESY in which the correlations between H-11 and H-12, H-1 and H-15, H-2 and H-14 were observed, respectively. Thus structure of 10 was established as 6-acetoxy-11,12-epoxy-drim-7-ene-9,11-diol. The metabolite 10 has been known as the reduction product, 6-O-acethylpereniporin A (10) from cinnamodial (3) [17] . The partial 1 H NMR data of the synthetic product (10) were reported, however, the assignment of all of the protons remained to be clarified and its 13 C NMR data were not presented. In Table 2 , the assignment of all of both protons and carbons of the metabolite (10) were presented. ) and a conjugated double bond (211.4 nm) by IR and UV spectra. The presence of each functional group was determined by the 1 H and 13 C NMR spectra as well as HMBC spectrum in which the connectivity between H-7 and C-9 and C-12, and H-11 and C-8, 9 and 12 was shown, respectively. On the basis of the above data, the structure of 11 was deduced to be 6-acetoxy-11,12-epoxy-12-oxodrim-7-ene-9-ol. In fact this compound was isolated from Cinnamosma fragrans and Capsicodendron dinisii belonging to the same family, Cannelaceae and named cinnamosmolide [15, 16, 18] . , and a methylene ( C 68.2) on carbon attached an oxygen function, respectively. The conclusive structure of 12 was established by its HMBC spectrum. It showed the correlation between H-5 and C-6, 9, 10, H-7 and C-6, 8, 9, and H-13 and C-1, 9 and 10, respectively. Thus the structure was deduced as 11,12-epoxy-6,12-dioxo-drim-8-ene (12) which was known as fragrolide isolated from Cinnamosma fragrans [16, 19] . All of the spectral data of 12 were similar to those of the natural product.
Biotransformation of 9-hydroxy-11, 12-diacetoxy-drim-7-ene (4): Warburganal (13) isolated from Warburgia ugandensis has been known to show insect antifeedant activity [20] . Warburganal is 9-hydroxypolygodial. In order to obtain some functional metabolites from 13, the partial synthesis of 13 was performed as shown in figure 5 [21] , however, the reaction mixture did not contain warburganal, Thus, the intermediate, 9-hydroxy-11,12-diacetoxydrim-7-ene (4, 50 mg) prepared from 2 by acetylation was incubated by A. niger in the same manner as previously described for 2 days to give a hydroxylated metabolite (15, 47 .2%) as colorless oil ( Figure 5 ). C NMR spectra of 15 (Table 3) were very similar to those of the substrate (4) ( Table 3 ) except for the presence of a hydroxymethine signal [ H , 3.31 (1H, d) and  C 78.1], indicating that compound 15 possessed an additional secondary hydroxy group on one of the two cyclohexane rings. The position of this functional group at C-3 was established by cross peaks of H-1 to C-3, H-13 and H-14 to C-3 in HMBC spectrum ( Figure 6a ) and its configuration was also confirmed to be 3 by the NOE correlation (Figure 6b ) of H-3 to H-1, H-5 and H-14. Consequently the structure of 15 was accomplished as 11,12-diacetoxy-drim-7-ene-3,9-diol. added and incubated for a couple days, however, no metabolites were obtained. As described in the previous section, two aldehyde groups were reduced to give sacculatadiol (6, 200 mg) by LiAlH 4 which was further biocoverted by the same fungus for 15 days and the crude metabolites were purified by the same method as described earlier to obtain (16, 1.6%), (17, 6 .7%), (18, 6 .1%), and 19 as an acetate (19a) (Figure 7 ). The HREIMS and EIMS of compound 16 showed the molecular formula as C 17 H 24 O 4. The IR absorption bands at a 3400-3100 cm -1 (broad), 1760 and 1706 cm -1 showed the presence of a -lactone and a carboxyl groups which were confirmed by the 13 C NMR signals at  C 170.1 and  C 178.6 . In the 13 C NMR, two olefinic methyls, a methyl carbinol and an olefinic methine disappeared from that of the substrate (6) and totally 17 carbon signals appeared including two carbonyl carbon signals, indicating that 16 was trinorsacculatanolide monocarboxylic acid without an isopropeny group attached in sacculatadiol (6) . The location of both a -lactone and a carboxylic acid of 16 were determined by the correlation of H-11 to C-8, 9, 10 and 12, and H-15 and H-16 to C-17 in HMBC spectrum. Thus, the structure of 16 was elucidated as 11,12-epoxy-12-oxo-trinorsacculat-7-en-17-oic acid.
The molecular formula of 17 was deduced to be C 20 C NMR signals of 17 were very similar to those of 16, except for the presence of the secondary hydroxy group, and an olefinic methyl, indicating that 17 possessed the same sacculatenolide skeleton as that of 16 with a -hydroxy group at C-3 and a carboxylic group at C-18. This presumption was supported by the cross-peaks of H-17 to C- 15 16, 18, 19 and 20 , and H-3 to C-1, 2, 4, 14 and 15, along with the correlations of H-11 to C-9, 8, 10 and 12 in the HMBC spectrum ( Figure 8a ). The stereochemistry of the secondary hydroxy group at C-3 and geometry between C-17 and C-18 were established to be  and E configuration by the NOESY spectrum ( Figure 8b 1683 cm -1 ;  C 171.7) and -hydroxy group (  3.51, m; C 73.9) and its 1 H and 13 C NMR signals (Table 5) are very similar to those of the original sacculatadiol (6) and except for the absence of one allylic methyl and the presence of a secondary alcohol in 18, indicating that the structure 18 was 3, 11, 12-trihydroxy-sacculat-7,17-dien-20-oic acid. This prediction was further confirmed by HMBC correlations (Figure 9a The original metabolite of 19 was difficult to isolate as a pure state, therefore, it was acetylated with acetic anhydride and pyridine to afford a triacetate (19a) after the absence of an acetoxy group in the original metabolite mixture was confirmed by the 1 H and 13 C NMR spectra (Table 5 ). Its molecular formula C 26 H 42 O 7 was suggested by HREIMS, the 1 H and 13 C NMR and HMQC spectra in which 3 acetoxy-, 2 methylenes and one methine attached to oxygen function, one trisubstituted double bond, a dimethyl carbinol, together with 5 sp 3 methylenes, 2-methyls, 2 sp 3 methines and 2 quaternary carbons were observed. The IR spectrum of 19a showed the presence of a hydroxy (3502 cm -1 ) and an ester group (1738 cm -1 ). The 1 H and 13 C NMR signal patterns of 19a were similar to those of compound 4, except for the presence of a dimethyl carbinol and one more acetoxy group in 19a, indicating that the structure of 19a was suggested to be 11,12,17-triacetoxy-sacculat-7-ene-18-ol. The above presumption was confirmed by HMBC correlations of H-17 to C-16, C-19 and C-20, as well as an acetoxy carbon at C-17, and H-19 and H-20 corresponding to the tertiary dimethyl group to C-17 and C-18, and H-11 and H-12 to C-11 and C-12-acetoxy carbons. Thus the structure of the original metabolite was sacculat-7-ene-11,12,17,18-tetraol (19) . The absolute configuration at C-17 remained to be clarified.
Two times bigger amount of sacculatadiol (6, 400 mg) was fed by A. niger in the same medium as described above to afford three more metabolites, (20, 3 .9%), (21, 0.78%) and (22, 0.86%), along with (17, 44%) and (18, 1.1%) (figure 10).
Compound 20 had a molecular formula, C 20 H 28 O 5 based on the HREIMS. The presence of a carboxyl and an ester groups was suggested by IR absorption bands at 3511-3293 cm -1 and 1743 and 1737 cm -1 . Analysis of 1 H and 13 C NMR spectra (Table 6) showed that compound 20 possessed the same structure as that of compound 
17.
The only difference was the position of the secondary hydroxyl group. In order to clarify this problem, HMBC and NOESY were measured. HMBC cross-peaks from H-1 to C-9, 10, 13 and H-2, 3 and H-13 to C-1 established the location of the secondary hydroxy group at C-1. Furthermore, the presence of a 11,12-olide and a carboxylic acid at C-18 was confirmed by HMBC cross-peaks from H-11 to C8, 9, 10 and 12, H-17 to C-15, 16, 19 and 20, and H-19 to C-17, 18 and 20. The stereochemistry of the hydroxyl group at C-1 was also established as  by NOESY in which the correlations of H-1 and H-3, H-5 and H-9 were observed. Thus the structure 20 was predicted as 1-hydroxy-11,12-epoxy-12-oxo-sacculat-7,17-dien-20-oic acid. However, the position of the absorption band at 1737 cm -1 in the IR spectrum of 20 is higher than that of the -unsaturated carboxylic acid (17) , indicating that the proposed structure was not fit to the proposed structure although all of the other spectral data were suitable to the proposed structure. This discrepancy is now under consideration. (Table 6 ) showed that 21 contained a hydroxyl group, the same unsaturated -lactone as shown in 16, 17 and 20 and the NMR spectra resembled those of the above mentioned sacculatenolides, only difference was that 21 had a hydroxy group (3450 cm -1 ;  C , 77.1) on quaternary carbon and two more methyls connected to tertiary carbon attached on oxygen function. On the basis of the above spectral data, one remaining oxygen was deduced to be an ether suggesting that the structure 21 was 5-hydroxy-11,12,17,18-diepoxy-12-oxo-sacculat-7-ene. This presumption was also established by the cross-peaks of HMBC, which showed correlation of H-3, H-14 to C-5, H-13 to C-1, 5, 9 and 10, H-11 to C-8 and C-12, H-19 and 20 to C-17 and 18. The stereochemistry of the tertiary hydroxy group at C-5 was also established as  by the correlation of NOESY. The cross peaks were observed between H-13 and H-14, H-1 and H-13 and H-14, H-11 and H-13, H-6 and H-13, and H-1 and H-9. The stereochemistry of the epoxide remained to be determined.
The 1 H and 13 C NMR spectra (Table 7 ) of the final metabolite 22, C 20 H 32 O 4 , which was determined by HREIMS, were very similar to those of the substrate 6. Only difference was that one of two allylic methyls in 6 was replaced by an -unsaturated carboxylic acid which was confirmed by the broad (3500-3381 cm-1) and sharp absorption bands (1684 cm -1 ) of IR spectrum and the presence of  C 171.9 in the 13 C NMR spectrum. The both NMR spectra resembled those of 18. Only difference was that 3-hydroxy group disappeared in 22. On the basis of the above spectral data, the structure of 22 was easily deduced as 11,12-dihydroxysacculat-7,17-dien-20-oic acid. This assumption was supported by the presence of the same HMBC cross-peaks (H-17 Metabolic pathways of polygodiol (2) and cinnamodial (3), and sacculatadiol (6) : From the metabolites of compound 2, two metabolic pathways are suggested as shown in Figure 11 . The route (A) shows the stereo-selective direct introduction of the hydroxy group at C-3 to yield the metabolite 7, followed by oxidation to produce the 3-oxodrim-7-ene-11,12-diol (9). The route (B) is also direct hydroxylation at C-15 of 2. Cinnamodial (3) was converted to the hemiacetal and -unsaturated lactones. It is suggested that there are two metabolic pathways for the production of the hemiacetals and -lactones from cinnamodial (3). In the route (A), one of the aldehyde at C-9 was reduced enzymatically, to give the C-9 primary alcohol, followed by cyclization to give a C-12-hemiacetal, which is oxidized to give cinnamosmolide (11), followed by dehydration and migration of the trisubstituted double bond or hydrogenation, followed by dehydration to afford the stable -unsaturated -lactone which is reduced to give 6-hydroxy product, then oxidation to furnish fragrolide (12) . In the second route (B), the aldehyde at C-8 is reduced to give C-8 primary alcohol, followed by the direct cyclization to produce compound (10) (Figure 12 ).
There are two biogenetic pathways of sacculatadiol (6) . The first route (A) is that 6 is converted to C-18 carboxylic acid to produce compound 22, followed by hydroxylation at C-1 and lactonization between C-11 and C-12 to furnish compound 20. The same carboxylic diol (22) is further oxidized to give the triol (18), followed by lactonization to afford 17. The second route (B) includes that the formation of a 17,18-epoxide (23) from 6, followed by hydroxylation at C-5 and lactonization to give 5-hydroxy-17,18-epoxysacculatenolide (21) . The epoxide is further hydrated to give 17,18-diol, followed by oxidation to give trinorsacculatenolide-17-oic acid (16) (Figure 13 ). In conclusion, the drimane sesquiterpene dialdehyde, polygodial (1) and cinnamodial (3) and sacculatane diterpene dialdehyde, sacculatal (5) which show pungent taste and interesting biological activities such as antimicrobial, piscicidal, and anti-HIV activity were incubated by the black fungus, Aspergillus niger. From the former two dialdehydes, their metabolites were not obtained because they possess potent antifungal activity [22] . The dihydro derivative, polygodiol (2) and 11,12-diacetoxy-drim-7-ene-9-ol (4) were smoothly biotransformed to give 3-hydroxy products (7, 15) in good yield together with 3-oxo-(9) and 15-hydroxypolygodiol (8) . The present method shows the highly efficient production of 3-hydroxypolygodiol (7) possessing insect antifeedant activity [23] since a high amount of polygodial (1) is easily available from the Polygonaceae, Canellaceae and Winteraceae plants [24] . Cinnamodial (3) was converted to the hemiacetal and -unsaturated -lactones (10-12), however, 3-hydroxy and 3-oxo products were not obtained. In case of sacculatadiol (6) , the hydroxylation at C-3, lactonization between C-11 and C-12, and oxidation at C-17 and C-20 occurred to give the metabolites (17) (18) (19) (20) (21) (22) in small yields. These structures resembled those of the metabolites obtained from polygodiol (2) and cinnamodial (3). The biotransformation time of sacculatadiol was longer than that of polygodiol because the former substrate has bigger molecule than polygodiol.
Experimental
General: Specific rotations were measured on JASCO DIP-1000 or JASCO P-1030 at 19-22°C using CHCl 3 or MeOH. The UV and IR spectra were recorded on a Shimadzu UV-1650 and a Shimadzu FTIR-8400S or a Perkin Elmer FTIR, respectively. For the IR spectral measurement, the samples were absorbed on a powdered KBr surface and measured with the diffusion reflection method. The EI, CI and FAB Mass spectra including high resolution ones were measured with a JEOL 700 Mstation or JMS AX-500 at 70eV. [25] , followed by heating at 120-130℃. Column chromatography: Silica gel (Merck silica gel 70-230 and 230-400 mesh), Sephadex LH-20 (Pharmacia Fine Chemicals) and Cosmosil 75C18-OPN (Nakalai Tesque) were performed using n-hexane and EtOAc gradient or a mixture of CHCl 3 /MeOH (1:1) or CH 2 Cl 2 /MeOH (1:1) as the solvents. Preparative HPLC: Shimadzu LC-10AS/Shimadzu SPD-10A and RID-10A detectors or JASCO PU-2086 plus/JASCO UV-2070 and RI-2031 plus were used. COSMOSIL 5SL-II Waters (10 x 250 mm) and COSMOSIL 5C18-Ar-2 Waters (4.6 x 250 mm and 10 x 250 mm) columns were used for purification of each component.
Microorganisms and medium:
Aspergillus niger was isolated from soil in Osaka prefecture and was identified based on its physiologic and morphologic features. A Czapek-peptone medium {(1.5% glucose, 1.5% sucrose, 0.5% polypepton, 0.1% K 2 HPO 4 , 0.05% KCl, 0.05% MgSO 4 ・7H 2 O, 0.001% FeSO 4 ・7H 2 O} in distilled water, pH 7.0)} was used for the bioconversion of each substrate by A. niger.
Isolation of polygodial (1):
The pungent green ether extract (57. + (calcd for C 15 H 22 O 2 :234.1620). The spectral data (NMR, IR and MS) of 1 were identical to those of the authentic sample and the reference data [8] .
Reduction of polygodial (1): To LiAlH 4 (612 mg) suspended in dried diethyl ether (20 mL) was added polygodial (1) (750 mg) in dried diethyl ether (13 mL) and stirred for 3 hr at 0.5 o C. Ethyl acetate (20 mL) was added to the reaction mixture at 0 o C and stirred for 10 min, then 1N HCl (10 mL) was added and the reaction mixture was partitioned between ethyl acetate and water, followed by evaporation of ethyl acetate to give the residue (711.2 mg) which was chromatographed on Sephadex LH-20 using CH 2 Cl 2 and MeOH (1:1) and silica gel using n-hexane-EtOAc gradient to afford polygodiol (2, 511.5 mg). 
Polygodiol

Biotransformation of polygodiol (2) (20 mg x 1) by Aspergillus niger:
An Erlenmeyer flask (500 mL) containing 200 mL of Czapek-peptone medium was inoculated with a suspension of A. niger and incubated at 30 °C for 3 days in a rotary shaker operating at 100 rpm. After full growth of the microorganisms, a solution of polygodial (2, 20 mg) was added to the culture medium of A. niger. The incubation was then continued for a further 3 days at 30°C. After the completion of the incubation time, the culture was filtered in vacuo and extracted twice with EtOAc under stirring. The EtOAc layer was dried over MgSO 4 and the solvent was evaporated in vacuo to give the crude extract (42.2 mg) which was chromatographed on silica gel with a gradient solvent system of nhexane-EtOAc by increasing the amount of EtOAc stepwise in 5% increments to afford drim-7-ene-3,11,12-triol (7, 15.5 mg). -7-ene-3,11,12-triol (7 (6), 223 (4), 188 (100), 173 (47), 133 (12), 96 (48), 91 (16), 81 (13), 41(10).
Drim
Acetylation of 7:
Compound (7) was dissolved in dried acetic anhydride (1.5 mL) and pyridine (1.5) and stirred at room temp. for 1 day. The reaction mixture was treated in usual manner to give drim-7-ene-3,11,12-yl triacetate (7a, 8.8 mg). 50 mg x 4) by A. niger: The treatment of 2 as mentioned above gave the metabolites (216.5 mg) which were subjected to column chromatography on SiO 2 (n-hexane/EtOAc gradient) to give 8 fractions. From Fr. 3, the original substrate (2, 16.5 mg) was recovered. Fr. 8 was further chromatographed on reverse phase SiO 2 (MeOH/H 2 O 6:4) to afford 6 fractions (8-1 to 8-6). From Fr. 8-6, drim-7-ene-11,12,14-triol (8, 3.5 mg) was obtained as a pure form. Fr. 8-8 was purified by prep. HPLC (MeOH/H 2 O: 6:4) to furnish 11,12-dihydroxydrim-7-ene-3-one (9, 8.2 mg) and drim-7-ene-3,11,12-triol (7, 43.6 mg). Biotransformation of cinnamodial (3): Cinnamodial (3) (100 mg x 2) isolated from the Malagasy folk medicinal plant, Cinnamosma fragrans collected in Madagascar was incubated with A. niger for 4 days in the same manner as described in the biotransformation of polygodiol (2) to give the metabolites (151.4 mg) which was chromatographed on reverse SiO 2 to divide into two fractions. The first fraction contained 6-acetoxy-11,12-epoxy-drim-7-ene-9,11-diol (10, 4.7 mg). The second Fr. was purified by prep. HPLC (n-hexane/EtOAc 1:1) to give cinnamosmolide (11, 0.1 mg) and fragrolide (12, 0.6 mg), respectively. Table 2 . The 1 H NMR spectral data was partially identical to those of the synthetic product (10) named 6-Oacetylpereniporin A, from cinnamodial (3) [17] . 
Drim-7-ene-3
Biotransformation of polygodiol (2) (
Drim
6-Acetoxy
Synthesis of 11,12-diacetoxy-drim-7-ene (14) and 11,12-diacetoxy-drim-7-ene-9-ol (4):
Polygodiol (2, 443 mg), which was obtained by the further reduction of polygodial (455. 4 mg) in the same method as describe earlier, was acetylated with anhydrous acetic anhydride (5 mL) and pyridine (5 mL). Treatment of the reaction mixture in usual manner gave 11, 12-diacetoxy-drim-7-ene (14, 359.9 mg) after purification using column chromatography (n-hexane/EtOAc). To compound (14, 245.5 mg) in dioxane was added SeO 2 (20.5 mg) and refluxed at 120 o C for 1 hr and the reaction mixture was filtered to give the residue (290.6 mg), which was further purified on column chromatography (n-hexane/EtOAc gradient) to furnish 11,12-diacetoxydrim-7-ene-9-ol (4, 140 mg). 1H, d) . 13 
11, 12-
Reduction of sacculatal (5):
To LiAlH 4 (630 mg) in dried diethyl ether (20 mL) was added sacculatal (5, 1.00 g), which was isolated from the Japanese liverwort, Pellia endiviifolia, in dried diethyl ether (10 mL). Treatment of the reaction mixture in the same manner as described above gave sacculatadiol (6, 893.7 mg).
Sacculatadiol ( Biotransformation of 6 by Aspergillus niger for 21 days. Sacculatadiol (6) (100 mg x 4) was treated with A. niger for 21 days. The crude metabolites (360.7 mg) was repeatedly chromato-graphed on Sephadex LH-20 (CH 2 Cl 2 /MeOH 1:1) and SiO 2 (n-hexane/ EtOAc gradient), and prep. HPLC (MeOH/H 2 O 4:1) to furnish 1-hydroxy-11,12-epoxy-12-oxo-sacculat-7,17-dien-20-oic acid (20, 3.9 mg), 5-hydroxy-11,12,17,18-diepoxy-12-oxo-sacculat-7-ene (21, 3.4 mg), 11,12-dihydroxysacculat-7,17-dien-20-oic acid (22, 3.8 mg) , and the same metabolites, (17, 2.0 mg) and (18, 5 .0 mg) which were obtained by the incubation of 6 for 15 days. Hydroxy-11,12-epoxy-12-oxo-sacculat-7 
1-
